

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.23777092 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.23777092 |
| 3 | fatty acid elongation (GO:0030497) | 5.75189726 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.73991741 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.73991741 |
| 6 | central nervous system myelination (GO:0022010) | 5.72040159 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 5.72040159 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.74585556 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.69724492 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.20142206 |
| 11 | bile acid biosynthetic process (GO:0006699) | 4.19456850 |
| 12 | cholesterol biosynthetic process (GO:0006695) | 4.09623860 |
| 13 | very long-chain fatty acid metabolic process (GO:0000038) | 4.08857410 |
| 14 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.06808603 |
| 15 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.00824904 |
| 16 | glyoxylate metabolic process (GO:0046487) | 3.90736962 |
| 17 | coenzyme catabolic process (GO:0009109) | 3.83836511 |
| 18 | heme transport (GO:0015886) | 3.80154420 |
| 19 | cysteine metabolic process (GO:0006534) | 3.77342871 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 3.72951377 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 3.71477832 |
| 22 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.68164010 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66209390 |
| 24 | protein carboxylation (GO:0018214) | 3.66209390 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.62351620 |
| 26 | sterol biosynthetic process (GO:0016126) | 3.62022196 |
| 27 | bile acid metabolic process (GO:0008206) | 3.61490791 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.59607687 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 3.58607681 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.57732267 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.54649313 |
| 32 | tyrosine metabolic process (GO:0006570) | 3.54431924 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.53034588 |
| 34 | response to methylmercury (GO:0051597) | 3.51526938 |
| 35 | acyl-CoA biosynthetic process (GO:0071616) | 3.49678383 |
| 36 | thioester biosynthetic process (GO:0035384) | 3.49678383 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.46049196 |
| 38 | myelin maintenance (GO:0043217) | 3.45334695 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.44740114 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.44740114 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.44740114 |
| 42 | urea metabolic process (GO:0019627) | 3.40869431 |
| 43 | urea cycle (GO:0000050) | 3.40869431 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 3.40560445 |
| 45 | glutamate metabolic process (GO:0006536) | 3.33459476 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.30136058 |
| 47 | acetyl-CoA metabolic process (GO:0006084) | 3.28857266 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.27156565 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.24383651 |
| 50 | intestinal cholesterol absorption (GO:0030299) | 3.23921658 |
| 51 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.23406257 |
| 52 | ensheathment of neurons (GO:0007272) | 3.23340399 |
| 53 | axon ensheathment (GO:0008366) | 3.23340399 |
| 54 | regulation of complement activation (GO:0030449) | 3.23101811 |
| 55 | regulation of lipoprotein metabolic process (GO:0050746) | 3.22311656 |
| 56 | cholesterol efflux (GO:0033344) | 3.21303104 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.21277897 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.21277897 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.21277897 |
| 60 | ethanol oxidation (GO:0006069) | 3.18907705 |
| 61 | myelination (GO:0042552) | 3.18735956 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.18197401 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.14469091 |
| 64 | acylglycerol homeostasis (GO:0055090) | 3.14469091 |
| 65 | iron coordination entity transport (GO:1901678) | 3.14252890 |
| 66 | thioester metabolic process (GO:0035383) | 3.13606400 |
| 67 | acyl-CoA metabolic process (GO:0006637) | 3.13606400 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 3.13317556 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.12587010 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.10899113 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.10899113 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 3.09585468 |
| 73 | cofactor catabolic process (GO:0051187) | 3.08665264 |
| 74 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.07743796 |
| 75 | negative regulation of lipase activity (GO:0060192) | 3.06666376 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.06467983 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 3.05005711 |
| 78 | adhesion of symbiont to host (GO:0044406) | 3.04646857 |
| 79 | cholesterol metabolic process (GO:0008203) | 3.04062834 |
| 80 | opsonization (GO:0008228) | 3.01753744 |
| 81 | regulation of cholesterol metabolic process (GO:0090181) | 2.97254698 |
| 82 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.96727304 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 2.95303547 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 2.94108626 |
| 85 | epoxygenase P450 pathway (GO:0019373) | 2.93750755 |
| 86 | cholesterol homeostasis (GO:0042632) | 2.92742494 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 2.92217141 |
| 88 | sterol homeostasis (GO:0055092) | 2.88902333 |
| 89 | protein-lipid complex assembly (GO:0065005) | 2.88202535 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.88020030 |
| 91 | angiotensin maturation (GO:0002003) | 2.85981500 |
| 92 | fibrinolysis (GO:0042730) | 2.85594590 |
| 93 | dicarboxylic acid catabolic process (GO:0043649) | 2.85391424 |
| 94 | sterol metabolic process (GO:0016125) | 2.84907033 |
| 95 | homocysteine metabolic process (GO:0050667) | 2.83503627 |
| 96 | bile acid and bile salt transport (GO:0015721) | 2.83120473 |
| 97 | linoleic acid metabolic process (GO:0043651) | 2.82594097 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 2.82460079 |
| 99 | negative regulation of sterol transport (GO:0032372) | 2.82256748 |
| 100 | negative regulation of cholesterol transport (GO:0032375) | 2.82256748 |
| 101 | positive regulation of p38MAPK cascade (GO:1900745) | 2.82174834 |
| 102 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80189441 |
| 103 | cellular glucuronidation (GO:0052695) | 2.79763039 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 2.78661309 |
| 105 | regulation of cholesterol storage (GO:0010885) | 2.77851671 |
| 106 | serine family amino acid catabolic process (GO:0009071) | 2.77817413 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 2.76147527 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 2.75885212 |
| 109 | ethanol metabolic process (GO:0006067) | 2.75765528 |
| 110 | phospholipid efflux (GO:0033700) | 2.73943575 |
| 111 | glycosphingolipid catabolic process (GO:0046479) | 2.71678915 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.66416485 |
| 113 | amyloid precursor protein catabolic process (GO:0042987) | 2.65453030 |
| 114 | low-density lipoprotein particle clearance (GO:0034383) | 2.64980614 |
| 115 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.63266706 |
| 116 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61149980 |
| 117 | vitamin D metabolic process (GO:0042359) | 2.57245997 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 2.54371346 |
| 119 | L-amino acid import (GO:0043092) | 2.53972292 |
| 120 | regulation of fever generation (GO:0031620) | 2.53962164 |
| 121 | regulation of vitamin metabolic process (GO:0030656) | 2.52049461 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 2.51988373 |
| 123 | sodium ion export (GO:0071436) | 2.50290588 |
| 124 | glycolipid catabolic process (GO:0019377) | 2.48497002 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47850971 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43093604 |
| 127 | glucocorticoid biosynthetic process (GO:0006704) | 2.41018231 |
| 128 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.40778251 |
| 129 | positive regulation of steroid metabolic process (GO:0045940) | 2.39552167 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.38857694 |
| 131 | virion attachment to host cell (GO:0019062) | 2.38857694 |
| 132 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.38750842 |
| 133 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.37066850 |
| 134 | positive regulation of heat generation (GO:0031652) | 2.36329104 |
| 135 | acute-phase response (GO:0006953) | 2.35640162 |
| 136 | cyclooxygenase pathway (GO:0019371) | 2.35323876 |
| 137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.34822911 |
| 138 | cellular sodium ion homeostasis (GO:0006883) | 2.31067855 |
| 139 | positive regulation of lipid storage (GO:0010884) | 2.29443325 |
| 140 | regulation of mononuclear cell migration (GO:0071675) | 2.29300350 |
| 141 | detection of molecule of bacterial origin (GO:0032490) | 2.28169020 |
| 142 | lipoprotein transport (GO:0042953) | 2.24524615 |
| 143 | regulation of podosome assembly (GO:0071801) | 2.22282477 |
| 144 | cell-cell junction maintenance (GO:0045217) | 2.21612815 |
| 145 | protein-lipid complex subunit organization (GO:0071825) | 2.19015578 |
| 146 | activation of MAPKKK activity (GO:0000185) | 2.18133702 |
| 147 | regulation of p38MAPK cascade (GO:1900744) | 2.16645672 |
| 148 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.14711356 |
| 149 | oligosaccharide catabolic process (GO:0009313) | 2.13970159 |
| 150 | fructose metabolic process (GO:0006000) | 2.13616983 |
| 151 | exogenous drug catabolic process (GO:0042738) | 2.13578959 |
| 152 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.12755981 |
| 153 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.11657552 |
| 154 | amino acid import (GO:0043090) | 2.11382945 |
| 155 | cellular response to cadmium ion (GO:0071276) | 2.10347012 |
| 156 | glucocorticoid metabolic process (GO:0008211) | 2.10080347 |
| 157 | negative regulation of lipid transport (GO:0032369) | 2.08430218 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.07034290 |
| 159 | ceramide catabolic process (GO:0046514) | 2.05590379 |
| 160 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.04958589 |
| 161 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.03545060 |
| 162 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.02464781 |
| 163 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.01944034 |
| 164 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.00755089 |
| 165 | cellular response to epinephrine stimulus (GO:0071872) | 1.99736118 |
| 166 | cell junction maintenance (GO:0034331) | 1.99558329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.19937630 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39718104 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.75987272 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.60298571 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.15347583 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.93003540 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.73309521 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62457930 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.55627774 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.92123134 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.90939217 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89118242 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82052447 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74996538 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71424205 |
| 16 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64119745 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60543234 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59270165 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58359389 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.58215357 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56860674 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55482494 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54085250 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53423006 |
| 25 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.53415216 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50206988 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48078981 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42175411 |
| 29 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41607166 |
| 30 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41607166 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39997255 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36617087 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35925186 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34611890 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34468392 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33927891 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33632330 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33158167 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32676729 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29928197 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29928197 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29694180 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26545065 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23209533 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22873887 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21992292 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20467334 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19994844 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19733817 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17587314 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17403187 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17129353 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16237033 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16026047 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15676454 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14165499 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13062494 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12974128 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12721948 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12575241 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11877582 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11543513 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11482837 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08480364 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07512868 |
| 66 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07329532 |
| 67 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06725037 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06560844 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06191738 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05740503 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04333769 |
| 72 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03309943 |
| 73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03032112 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02142477 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02085564 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01585295 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01454917 |
| 78 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01391947 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99853934 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99298290 |
| 81 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98889102 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98885665 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98433620 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98036124 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97295888 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96676001 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96111176 |
| 88 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95872511 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95749376 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95064984 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94702379 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94032007 |
| 93 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92941032 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92625771 |
| 95 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91985370 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91047716 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90206869 |
| 98 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89875996 |
| 99 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.89233230 |
| 100 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87410683 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86685943 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86244410 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84428366 |
| 104 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.84335638 |
| 105 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84247918 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84075650 |
| 107 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84011207 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83974845 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83967227 |
| 110 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83570953 |
| 111 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83268979 |
| 112 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83191237 |
| 113 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82923341 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.82326840 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81889698 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81493623 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81455515 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81238693 |
| 119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80281573 |
| 120 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79865805 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79434115 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79013159 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78194241 |
| 124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77472656 |
| 125 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76445901 |
| 126 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76344287 |
| 127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.76314535 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76227034 |
| 129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76214722 |
| 130 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76204217 |
| 131 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.75586251 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75159256 |
| 133 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.74574078 |
| 134 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74188395 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72893799 |
| 136 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72422971 |
| 137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72191913 |
| 138 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71291341 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71224461 |
| 140 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.71147753 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70875756 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.70267785 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.70143400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.03835956 |
| 2 | MP0005360_urolithiasis | 5.21868491 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.68188963 |
| 4 | MP0005365_abnormal_bile_salt | 4.25959911 |
| 5 | MP0003303_peritoneal_inflammation | 4.03204341 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.58796647 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.52730660 |
| 8 | MP0008004_abnormal_stomach_pH | 3.29730238 |
| 9 | MP0003252_abnormal_bile_duct | 2.97904006 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.87672355 |
| 11 | MP0003195_calcinosis | 2.83966885 |
| 12 | MP0005083_abnormal_biliary_tract | 2.82537872 |
| 13 | MP0000920_abnormal_myelination | 2.79833356 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.57443274 |
| 15 | MP0009840_abnormal_foam_cell | 2.52481394 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.50819350 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.32355686 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.30377810 |
| 19 | MP0003329_amyloid_beta_deposits | 2.26510368 |
| 20 | MP0003724_increased_susceptibility_to | 2.18460766 |
| 21 | MP0006082_CNS_inflammation | 2.14973676 |
| 22 | MP0005332_abnormal_amino_acid | 2.05326664 |
| 23 | MP0003690_abnormal_glial_cell | 2.05154810 |
| 24 | MP0003879_abnormal_hair_cell | 2.04377112 |
| 25 | MP0003075_altered_response_to | 2.04202758 |
| 26 | MP0004510_myositis | 1.96611546 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.94645385 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.79647204 |
| 29 | MP0004885_abnormal_endolymph | 1.76013525 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.67548216 |
| 31 | MP0000604_amyloidosis | 1.63623196 |
| 32 | MP0004858_abnormal_nervous_system | 1.62477659 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.60929114 |
| 34 | MP0003868_abnormal_feces_composition | 1.60761922 |
| 35 | MP0005451_abnormal_body_composition | 1.60153299 |
| 36 | MP0004270_analgesia | 1.58884316 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.57498135 |
| 38 | MP0005166_decreased_susceptibility_to | 1.48825847 |
| 39 | MP0003436_decreased_susceptibility_to | 1.48312021 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.45555022 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.42891006 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.34549146 |
| 43 | MP0000579_abnormal_nail_morphology | 1.29862321 |
| 44 | MP0000609_abnormal_liver_physiology | 1.26526987 |
| 45 | MP0005409_darkened_coat_color | 1.25150398 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24585462 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.23747423 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.23638223 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.22830408 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.21878060 |
| 51 | MP0003011_delayed_dark_adaptation | 1.20775416 |
| 52 | MP0002796_impaired_skin_barrier | 1.20489229 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.16896087 |
| 54 | MP0000383_abnormal_hair_follicle | 1.15809039 |
| 55 | MP0009785_altered_susceptibility_to | 1.12138956 |
| 56 | MP0003632_abnormal_nervous_system | 1.09564536 |
| 57 | MP0009764_decreased_sensitivity_to | 1.08671116 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.08463644 |
| 59 | MP0000462_abnormal_digestive_system | 1.05637902 |
| 60 | MP0005408_hypopigmentation | 1.04757258 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.04634667 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.04621405 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.02982903 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.02412386 |
| 65 | MP0003122_maternal_imprinting | 1.01347852 |
| 66 | MP0004947_skin_inflammation | 1.01319401 |
| 67 | MP0003634_abnormal_glial_cell | 1.00666763 |
| 68 | MP0000566_synostosis | 0.99806582 |
| 69 | MP0005535_abnormal_body_temperature | 0.99256438 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.98831949 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 0.98431974 |
| 72 | MP0010155_abnormal_intestine_physiology | 0.97917427 |
| 73 | MP0004742_abnormal_vestibular_system | 0.97537242 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 0.97480211 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.96365413 |
| 76 | MP0000647_abnormal_sebaceous_gland | 0.95464720 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.95439905 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.94643431 |
| 79 | MP0003880_abnormal_central_pattern | 0.92935704 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 0.92669213 |
| 81 | MP0001486_abnormal_startle_reflex | 0.92128009 |
| 82 | MP0004381_abnormal_hair_follicle | 0.92035114 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.91818322 |
| 84 | MP0002419_abnormal_innate_immunity | 0.91124057 |
| 85 | MP0004043_abnormal_pH_regulation | 0.90197030 |
| 86 | MP0003633_abnormal_nervous_system | 0.89575548 |
| 87 | MP0003631_nervous_system_phenotype | 0.89546735 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.87837586 |
| 89 | MP0002063_abnormal_learning/memory/cond | 0.87814983 |
| 90 | MP0001851_eye_inflammation | 0.86464838 |
| 91 | MP0000343_altered_response_to | 0.85616191 |
| 92 | MP0005025_abnormal_response_to | 0.85158436 |
| 93 | MP0005670_abnormal_white_adipose | 0.84920404 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.84533966 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.84477078 |
| 96 | MP0001661_extended_life_span | 0.82728186 |
| 97 | MP0005023_abnormal_wound_healing | 0.82669228 |
| 98 | MP0005334_abnormal_fat_pad | 0.82607546 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.82008287 |
| 100 | MP0003635_abnormal_synaptic_transmissio | 0.81106962 |
| 101 | MP0000778_abnormal_nervous_system | 0.80877221 |
| 102 | MP0008874_decreased_physiological_sensi | 0.80204073 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.78896014 |
| 104 | MP0004272_abnormal_basement_membrane | 0.78805688 |
| 105 | MP0009278_abnormal_bone_marrow | 0.77483072 |
| 106 | MP0005171_absent_coat_pigmentation | 0.76743893 |
| 107 | MP0002272_abnormal_nervous_system | 0.76736386 |
| 108 | MP0001881_abnormal_mammary_gland | 0.75462460 |
| 109 | MP0004142_abnormal_muscle_tone | 0.75153498 |
| 110 | MP0008469_abnormal_protein_level | 0.74858199 |
| 111 | MP0002229_neurodegeneration | 0.73977287 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.73856215 |
| 113 | MP0004130_abnormal_muscle_cell | 0.73747429 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.73588969 |
| 115 | MP0000467_abnormal_esophagus_morphology | 0.72733728 |
| 116 | MP0002822_catalepsy | 0.72657788 |
| 117 | MP0003091_abnormal_cell_migration | 0.72135216 |
| 118 | MP0005647_abnormal_sex_gland | 0.71539810 |
| 119 | MP0003123_paternal_imprinting | 0.71536984 |
| 120 | MP0001177_atelectasis | 0.70189000 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.69178863 |
| 122 | MP0005164_abnormal_response_to | 0.68827076 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.68435419 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.67324018 |
| 125 | MP0003448_altered_tumor_morphology | 0.66649597 |
| 126 | MP0001970_abnormal_pain_threshold | 0.66218329 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.64455245 |
| 128 | MP0001529_abnormal_vocalization | 0.64264338 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.64005887 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.63150726 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.63040490 |
| 132 | MP0005448_abnormal_energy_balance | 0.62791866 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.62398695 |
| 134 | MP0005275_abnormal_skin_tensile | 0.61686415 |
| 135 | MP0002971_abnormal_brown_adipose | 0.61522735 |
| 136 | MP0002064_seizures | 0.60831332 |
| 137 | MP0000747_muscle_weakness | 0.60768210 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.60528273 |
| 139 | MP0000427_abnormal_hair_cycle | 0.59989923 |
| 140 | MP0002254_reproductive_system_inflammat | 0.59907242 |
| 141 | MP0009115_abnormal_fat_cell | 0.59466172 |
| 142 | MP0001764_abnormal_homeostasis | 0.58831987 |
| 143 | MP0005501_abnormal_skin_physiology | 0.57061286 |
| 144 | MP0004859_abnormal_synaptic_plasticity | 0.56624162 |
| 145 | MP0004264_abnormal_extraembryonic_tissu | 0.56498823 |
| 146 | MP0004134_abnormal_chest_morphology | 0.56241103 |
| 147 | MP0001340_abnormal_eyelid_morphology | 0.55976982 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.55626913 |
| 149 | MP0003186_abnormal_redox_activity | 0.55482406 |
| 150 | MP0009697_abnormal_copulation | 0.54996504 |
| 151 | MP0005410_abnormal_fertilization | 0.54464749 |
| 152 | MP0001440_abnormal_grooming_behavior | 0.53915066 |
| 153 | MP0000377_abnormal_hair_follicle | 0.52596370 |
| 154 | MP0009053_abnormal_anal_canal | 0.52055597 |
| 155 | MP0000955_abnormal_spinal_cord | 0.51981660 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.51841407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.75777479 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69131879 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.50298076 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.38885526 |
| 5 | Xanthomatosis (HP:0000991) | 4.92290446 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.64503634 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.53597298 |
| 8 | Glomerulonephritis (HP:0000099) | 4.53504690 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.37380896 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.26225967 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.03873530 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.99708082 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.99708082 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.84701584 |
| 15 | Epidermoid cyst (HP:0200040) | 3.73758836 |
| 16 | Complement deficiency (HP:0004431) | 3.51480450 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47228695 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47228695 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47228695 |
| 20 | Fat malabsorption (HP:0002630) | 3.41991550 |
| 21 | Abnormality of the corticospinal tract (HP:0002492) | 3.34806609 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.30102448 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.19726025 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.18135256 |
| 25 | Termporal pattern (HP:0011008) | 3.08393086 |
| 26 | Insidious onset (HP:0003587) | 3.08393086 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08328243 |
| 28 | Hyperammonemia (HP:0001987) | 3.00644704 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98846843 |
| 30 | Parakeratosis (HP:0001036) | 2.94057820 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.92806518 |
| 32 | Malnutrition (HP:0004395) | 2.90549959 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.89155631 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.88901742 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.86048731 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.86048731 |
| 37 | Hypophosphatemic rickets (HP:0004912) | 2.84768431 |
| 38 | Disinhibition (HP:0000734) | 2.81644825 |
| 39 | Mutism (HP:0002300) | 2.79156398 |
| 40 | Steatorrhea (HP:0002570) | 2.78840566 |
| 41 | Nephritis (HP:0000123) | 2.76814554 |
| 42 | Ketosis (HP:0001946) | 2.73289819 |
| 43 | Hyperglycinemia (HP:0002154) | 2.73267805 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.70527966 |
| 45 | Action tremor (HP:0002345) | 2.68406991 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65687643 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.57140518 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.53118755 |
| 49 | Flat acetabular roof (HP:0003180) | 2.51559303 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.46941052 |
| 51 | Vascular calcification (HP:0004934) | 2.46929056 |
| 52 | Intention tremor (HP:0002080) | 2.46082894 |
| 53 | Cholecystitis (HP:0001082) | 2.45155812 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.45155812 |
| 55 | Turricephaly (HP:0000262) | 2.43085032 |
| 56 | Neuronal loss in central nervous system (HP:0002529) | 2.39998555 |
| 57 | Loss of speech (HP:0002371) | 2.39328098 |
| 58 | Amyloidosis (HP:0011034) | 2.39164577 |
| 59 | Onion bulb formation (HP:0003383) | 2.37881351 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.37076591 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36026997 |
| 62 | Orchitis (HP:0100796) | 2.34328929 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.33615786 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.32457253 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.29646053 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.29563338 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.28390922 |
| 68 | Joint hemorrhage (HP:0005261) | 2.27984707 |
| 69 | Abnormality of complement system (HP:0005339) | 2.26116119 |
| 70 | Coronal craniosynostosis (HP:0004440) | 2.24381991 |
| 71 | Spastic paraparesis (HP:0002313) | 2.22632865 |
| 72 | Axonal loss (HP:0003447) | 2.22452278 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20788407 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.20788407 |
| 75 | Optic neuritis (HP:0100653) | 2.18440696 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.18440696 |
| 77 | Spastic gait (HP:0002064) | 2.18312981 |
| 78 | Scanning speech (HP:0002168) | 2.16855293 |
| 79 | Skin nodule (HP:0200036) | 2.15822222 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14739676 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14739676 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14739676 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.11350843 |
| 84 | Myokymia (HP:0002411) | 2.11305543 |
| 85 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.09386626 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 2.08553541 |
| 87 | Hyperglycinuria (HP:0003108) | 2.08462338 |
| 88 | Abnormality of glycolysis (HP:0004366) | 2.08191543 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.08191543 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08159119 |
| 91 | Rickets (HP:0002748) | 2.06758258 |
| 92 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05383560 |
| 93 | Spastic tetraparesis (HP:0001285) | 2.02294342 |
| 94 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01355351 |
| 95 | Retinal atrophy (HP:0001105) | 2.00351419 |
| 96 | Hyporeflexia of lower limbs (HP:0002600) | 2.00291822 |
| 97 | Anomalous pulmonary venous return (HP:0010772) | 1.99620449 |
| 98 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.99611818 |
| 99 | Abnormal auditory evoked potentials (HP:0006958) | 1.99419771 |
| 100 | Hyperparathyroidism (HP:0000843) | 1.97086182 |
| 101 | Cerebral hemorrhage (HP:0001342) | 1.97042287 |
| 102 | Osteomalacia (HP:0002749) | 1.96668285 |
| 103 | Purpura (HP:0000979) | 1.95122951 |
| 104 | Nuclear cataract (HP:0100018) | 1.95101822 |
| 105 | Aplasia involving bones of the extremities (HP:0009825) | 1.93467577 |
| 106 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.93467577 |
| 107 | Aplasia of the phalanges of the hand (HP:0009802) | 1.93467577 |
| 108 | Ankle clonus (HP:0011448) | 1.93093733 |
| 109 | Ileus (HP:0002595) | 1.92194167 |
| 110 | Peripheral hypomyelination (HP:0007182) | 1.91590478 |
| 111 | Hepatocellular carcinoma (HP:0001402) | 1.91205082 |
| 112 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90989207 |
| 113 | Sensory axonal neuropathy (HP:0003390) | 1.90871349 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 1.90204566 |
| 115 | Peripheral demyelination (HP:0011096) | 1.89231491 |
| 116 | Spontaneous abortion (HP:0005268) | 1.88532269 |
| 117 | Widely patent fontanelles and sutures (HP:0004492) | 1.87598101 |
| 118 | Apathy (HP:0000741) | 1.86576099 |
| 119 | Hyperbilirubinemia (HP:0002904) | 1.86416993 |
| 120 | Cholelithiasis (HP:0001081) | 1.85886983 |
| 121 | Split foot (HP:0001839) | 1.85756152 |
| 122 | Delayed CNS myelination (HP:0002188) | 1.85104110 |
| 123 | Methylmalonic acidemia (HP:0002912) | 1.84898724 |
| 124 | Paraparesis (HP:0002385) | 1.84642284 |
| 125 | Autoamputation (HP:0001218) | 1.83926069 |
| 126 | Bronchomalacia (HP:0002780) | 1.83342467 |
| 127 | Infantile muscular hypotonia (HP:0008947) | 1.81947217 |
| 128 | Dementia (HP:0000726) | 1.81291143 |
| 129 | Abnormality of carpal bone ossification (HP:0006257) | 1.81251357 |
| 130 | Glomerulosclerosis (HP:0000096) | 1.80847991 |
| 131 | Acanthocytosis (HP:0001927) | 1.80817473 |
| 132 | Irritability (HP:0000737) | 1.80651783 |
| 133 | Myocardial infarction (HP:0001658) | 1.79118303 |
| 134 | Abnormality of vitamin metabolism (HP:0100508) | 1.78829995 |
| 135 | Confusion (HP:0001289) | 1.76974938 |
| 136 | Abnormality of serum amino acid levels (HP:0003112) | 1.76363249 |
| 137 | Gingivitis (HP:0000230) | 1.76202628 |
| 138 | Urinary incontinence (HP:0000020) | 1.74580323 |
| 139 | Back pain (HP:0003418) | 1.73266751 |
| 140 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73038600 |
| 141 | Dysmetria (HP:0001310) | 1.72988465 |
| 142 | Stridor (HP:0010307) | 1.72445175 |
| 143 | Diminished motivation (HP:0000745) | 1.71779822 |
| 144 | Enlarged kidneys (HP:0000105) | 1.71055081 |
| 145 | Muscle fiber splitting (HP:0003555) | 1.70378264 |
| 146 | Joint swelling (HP:0001386) | 1.69804057 |
| 147 | Abnormality of the pulmonary veins (HP:0011718) | 1.69767241 |
| 148 | Hypophosphatemia (HP:0002148) | 1.69687191 |
| 149 | Ketoacidosis (HP:0001993) | 1.69494013 |
| 150 | Bone pain (HP:0002653) | 1.68901550 |
| 151 | Sensorimotor neuropathy (HP:0007141) | 1.68603601 |
| 152 | Thin bony cortex (HP:0002753) | 1.68470567 |
| 153 | Renal tubular acidosis (HP:0001947) | 1.68237626 |
| 154 | Protuberant abdomen (HP:0001538) | 1.67576409 |
| 155 | Brushfield spots (HP:0001088) | 1.67289131 |
| 156 | Acne (HP:0001061) | 1.67252740 |
| 157 | Abnormality of the gallbladder (HP:0005264) | 1.65984774 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.65502159 |
| 159 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65293096 |
| 160 | Mitral stenosis (HP:0001718) | 1.64801806 |
| 161 | Lethargy (HP:0001254) | 1.64738504 |
| 162 | Partial duplication of thumb phalanx (HP:0009944) | 1.63944405 |
| 163 | Cupped ribs (HP:0000887) | 1.63782256 |
| 164 | Inappropriate behavior (HP:0000719) | 1.63564721 |
| 165 | Mixed hearing impairment (HP:0000410) | 1.62193110 |
| 166 | Abnormality of the parietal bone (HP:0002696) | 1.61454315 |
| 167 | Metaphyseal irregularity (HP:0003025) | 1.61249722 |
| 168 | Recurrent bacterial skin infections (HP:0005406) | 1.59873476 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.59727698 |
| 170 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.59374242 |
| 171 | Myositis (HP:0100614) | 1.58341674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.13853774 |
| 2 | RIPK1 | 4.07575237 |
| 3 | EPHB1 | 3.77595294 |
| 4 | PRPF4B | 2.95194762 |
| 5 | OXSR1 | 2.93164525 |
| 6 | FGFR2 | 2.67421130 |
| 7 | MET | 2.60197189 |
| 8 | BCKDK | 2.34019665 |
| 9 | WNK4 | 2.17019042 |
| 10 | PKN1 | 2.16957860 |
| 11 | IRAK3 | 2.14880566 |
| 12 | MAPKAPK5 | 2.11461387 |
| 13 | LATS1 | 2.00264033 |
| 14 | SIK1 | 1.97519786 |
| 15 | NTRK3 | 1.95172843 |
| 16 | BCR | 1.92411658 |
| 17 | NTRK1 | 1.89573130 |
| 18 | LIMK1 | 1.80725583 |
| 19 | AKT3 | 1.64103130 |
| 20 | PBK | 1.63808877 |
| 21 | TAOK2 | 1.61124415 |
| 22 | WNK1 | 1.59915047 |
| 23 | MAP3K11 | 1.54043649 |
| 24 | ERBB4 | 1.43625895 |
| 25 | MST1R | 1.40642918 |
| 26 | MAP3K2 | 1.36970967 |
| 27 | TAOK1 | 1.36429921 |
| 28 | CSNK1A1L | 1.36331376 |
| 29 | SGK2 | 1.35764004 |
| 30 | NTRK2 | 1.32968200 |
| 31 | CDC42BPA | 1.32671688 |
| 32 | PAK3 | 1.29351932 |
| 33 | MATK | 1.28992627 |
| 34 | CSNK1G3 | 1.26297134 |
| 35 | PDGFRA | 1.25227891 |
| 36 | CAMK2B | 1.24071240 |
| 37 | FGFR4 | 1.22554567 |
| 38 | SGK494 | 1.22250545 |
| 39 | SGK223 | 1.22250545 |
| 40 | KSR2 | 1.21929500 |
| 41 | CSNK1G2 | 1.18751542 |
| 42 | CAMK2G | 1.16409193 |
| 43 | ROCK2 | 1.15565146 |
| 44 | SGK3 | 1.15208193 |
| 45 | CSNK1G1 | 1.14339386 |
| 46 | TESK2 | 1.12745319 |
| 47 | DDR2 | 1.12711705 |
| 48 | RIPK4 | 1.11942716 |
| 49 | FER | 1.10989789 |
| 50 | PAK6 | 1.10854584 |
| 51 | ERN1 | 1.10167757 |
| 52 | MAP2K4 | 1.09386628 |
| 53 | DAPK2 | 1.07663694 |
| 54 | EPHA4 | 1.05222174 |
| 55 | CSK | 1.04218246 |
| 56 | UHMK1 | 1.03551367 |
| 57 | TYRO3 | 1.01455490 |
| 58 | MAP2K2 | 1.01226727 |
| 59 | CAMK2D | 1.01212504 |
| 60 | PIK3CA | 0.99980451 |
| 61 | MARK1 | 0.98713981 |
| 62 | GRK7 | 0.98327333 |
| 63 | INSRR | 0.97133598 |
| 64 | CAMK1G | 0.97030226 |
| 65 | PTK2 | 0.96855550 |
| 66 | FGFR3 | 0.96197802 |
| 67 | LATS2 | 0.93879454 |
| 68 | ICK | 0.93875992 |
| 69 | PDK2 | 0.93105353 |
| 70 | TRIB3 | 0.91045930 |
| 71 | PTK6 | 0.90707774 |
| 72 | JAK2 | 0.89924468 |
| 73 | JAK1 | 0.89322176 |
| 74 | TNIK | 0.89199740 |
| 75 | PDPK1 | 0.87304105 |
| 76 | PHKG2 | 0.86359636 |
| 77 | PHKG1 | 0.86359636 |
| 78 | ERBB2 | 0.86057155 |
| 79 | GSK3A | 0.84546446 |
| 80 | PRKD1 | 0.84344289 |
| 81 | TYK2 | 0.84244093 |
| 82 | EPHA2 | 0.83703425 |
| 83 | RET | 0.83614614 |
| 84 | MINK1 | 0.82573461 |
| 85 | FGR | 0.82427994 |
| 86 | PNCK | 0.82309046 |
| 87 | PIK3CG | 0.82233645 |
| 88 | DYRK1B | 0.77329231 |
| 89 | BLK | 0.74021644 |
| 90 | BMX | 0.73788307 |
| 91 | PDK1 | 0.73364442 |
| 92 | MAP3K7 | 0.72662741 |
| 93 | CAMK2A | 0.72621028 |
| 94 | MAP3K14 | 0.72484010 |
| 95 | FRK | 0.72453695 |
| 96 | CDK19 | 0.70781092 |
| 97 | MAP3K9 | 0.70433662 |
| 98 | TBK1 | 0.67560886 |
| 99 | PRKCZ | 0.66802012 |
| 100 | DYRK2 | 0.66469650 |
| 101 | SGK1 | 0.65336509 |
| 102 | CAMK4 | 0.65171208 |
| 103 | MAP3K3 | 0.64811227 |
| 104 | CAMKK1 | 0.64266083 |
| 105 | MAP2K1 | 0.63387790 |
| 106 | PRKCE | 0.62815756 |
| 107 | MAPK12 | 0.60787983 |
| 108 | PRKCQ | 0.60426159 |
| 109 | MAP3K5 | 0.60415885 |
| 110 | ABL2 | 0.60023562 |
| 111 | DMPK | 0.59883559 |
| 112 | CDK5 | 0.59440632 |
| 113 | NEK6 | 0.58298019 |
| 114 | PRKAA2 | 0.56520692 |
| 115 | NLK | 0.56424257 |
| 116 | EPHB2 | 0.55661383 |
| 117 | ACVR1B | 0.55211086 |
| 118 | MARK2 | 0.54841571 |
| 119 | STK38L | 0.54545261 |
| 120 | CDK14 | 0.53846714 |
| 121 | CAMK1D | 0.53607956 |
| 122 | MAP3K12 | 0.52708973 |
| 123 | BMPR2 | 0.52575626 |
| 124 | TGFBR2 | 0.51572341 |
| 125 | PRKD3 | 0.51108103 |
| 126 | CHUK | 0.50889974 |
| 127 | KSR1 | 0.50662224 |
| 128 | MAPK7 | 0.49816843 |
| 129 | CASK | 0.49503188 |
| 130 | STK38 | 0.49257532 |
| 131 | MOS | 0.49155452 |
| 132 | MUSK | 0.48968322 |
| 133 | IRAK2 | 0.48687208 |
| 134 | PRKACG | 0.48452456 |
| 135 | MAPK15 | 0.47496162 |
| 136 | FGFR1 | 0.47417090 |
| 137 | MAP3K1 | 0.46801530 |
| 138 | MAP2K3 | 0.46110873 |
| 139 | MAPK10 | 0.45424961 |
| 140 | MTOR | 0.45349917 |
| 141 | EPHA3 | 0.45093537 |
| 142 | PAK2 | 0.44988190 |
| 143 | RPS6KA2 | 0.44904416 |
| 144 | CDK15 | 0.44520933 |
| 145 | PDGFRB | 0.44347329 |
| 146 | PRKG1 | 0.44205207 |
| 147 | ZAP70 | 0.44126238 |
| 148 | FYN | 0.43995762 |
| 149 | CSNK1D | 0.43803249 |
| 150 | TRPM7 | 0.43436308 |
| 151 | LRRK2 | 0.43183351 |
| 152 | DAPK3 | 0.42975863 |
| 153 | TAOK3 | 0.42483189 |
| 154 | MAP3K4 | 0.41641330 |
| 155 | PRKACB | 0.40484390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.35017405 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35452552 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.31119777 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.98506778 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.73383527 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.51380496 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40495701 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.39689297 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33711139 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28961531 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22977378 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22527068 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19810622 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02442337 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98541486 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94722270 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93123295 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92796824 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92387457 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91674406 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89970651 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86326076 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83379803 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76076372 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.71654996 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63753946 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62139482 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60858039 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60368466 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55927257 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43346220 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41241435 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39136675 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.37883941 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36500655 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.33877428 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30901898 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29145334 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24482197 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23933282 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20834504 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19834414 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16683410 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13518842 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11226491 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.09561503 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09399136 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07959763 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05205216 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04628323 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01724499 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01030323 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00833005 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00153656 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98110567 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96583597 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94754159 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92010651 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90092852 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89297022 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.89152373 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.88726319 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88545482 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86457361 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86314057 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84779965 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.79360538 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78673229 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78392770 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77533654 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77319369 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.75059578 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74850815 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73995309 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73100121 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73077665 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72737928 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70896335 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70825332 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70364070 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69810548 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68569563 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67547444 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67526954 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67100163 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.66863538 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65125017 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64305262 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62885485 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58197168 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57977515 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54830879 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50550774 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50303434 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49951859 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49497280 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49364457 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48833991 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48785848 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47782698 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47586001 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47428715 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46820591 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46633091 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45732541 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45424482 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.45327849 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.45068230 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.45062392 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44934275 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.44779074 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42492600 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42482954 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41668409 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.41608618 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41245728 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.40554084 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39259051 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39089191 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38565222 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38041541 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.37073630 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37054421 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35557426 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33602607 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.27707296 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27302739 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.23787213 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22361412 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19581130 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19367580 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18675349 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17163481 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15094932 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14654213 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13861291 |
| 137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13565377 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12995713 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12725814 |
| 140 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.12710358 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.10466205 |
| 142 | Protein export_Homo sapiens_hsa03060 | 0.09449551 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09177009 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08484028 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.07627086 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.07455919 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.07440619 |
| 148 | Long-term depression_Homo sapiens_hsa04730 | 0.07180778 |
| 149 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.06789140 |
| 150 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05506987 |
| 151 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.05337665 |
| 152 | Salivary secretion_Homo sapiens_hsa04970 | 0.04063773 |

